Metrics to compare | RICHm | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRICHmPeersSector | |
|---|---|---|---|---|
P/E Ratio | 9.8x | 11.4x | −0.3x | |
PEG Ratio | −0.24 | 0.09 | 0.00 | |
Price/Book | 1.1x | 1.4x | 2.6x | |
Price / LTM Sales | 1.0x | 1.7x | 3.1x | |
Upside (Analyst Target) | - | 36.4% | 48.3% | |
Fair Value Upside | Unlock | 12.1% | 6.7% | Unlock |
Laboratorios Richmond S.A.C.I.F., together with its subsidiaries, develops, manufactures, and sells pharmaceutical products in Latin America, Africa, Asia, and the Middle East. It offers antiretroviral drugs for the treatment of human immunodeficiency virus; oncology and oncohematology drugs; cardiometabolism drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs, such as analgesics, antipsychotics, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company was incorporated in 1959 and is headquartered in Buenos Aires, Argentina.